{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:49:36Z","timestamp":1778694576092,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejphar.2019.172469","type":"journal-article","created":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T01:25:32Z","timestamp":1561166732000},"page":"172469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Zoledronic acid prevents the hepatic changes associated with high fat diet in rats; the potential role of mevalonic acid pathway in nonalcoholic steatohepatitis"],"prefix":"10.1016","volume":"858","author":[{"given":"Reham Hussein","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Tarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada Galal","family":"Hamam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samar F.","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejphar.2019.172469_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1359\/jbmr.2000.15.3.599","article-title":"Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol","volume":"15","author":"Adami","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.ejphar.2019.172469_bib2","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbadis.2015.05.015","article-title":"Recent insights on the role of cholesterol in non-alcoholic fatty liver disease","volume":"1852","author":"Arguello","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"5","key":"10.1016\/j.ejphar.2019.172469_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jcmgh.2015.06.011","article-title":"Angiogenesis and fibrogenesis in chronic liver diseases","volume":"1","author":"Bocca","year":"2015","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"key":"10.1016\/j.ejphar.2019.172469_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0168-8278(02)00430-0","article-title":"Current management of portal hypertension","volume":"38","author":"Bosch","year":"2003","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.ejphar.2019.172469_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cld.2007.02.006","article-title":"Non-alcoholic steatohepatitis and cancer","volume":"11","author":"Bugianesi","year":"2007","journal-title":"Clin. Liver Dis."},{"issue":"4","key":"10.1016\/j.ejphar.2019.172469_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jhep.2008.12.016","article-title":"Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH","volume":"50","author":"Caballero","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2019.172469_bib7","first-page":"225","article-title":"Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study","volume":"109","author":"Carpino","year":"2004","journal-title":"Ital. J. Anat. Embryol."},{"issue":"5","key":"10.1016\/j.ejphar.2019.172469_bib8","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/hep.26219","article-title":"Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models","volume":"57","author":"Coulon","year":"2013","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ejphar.2019.172469_bib9","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/jhep.2001.29628","article-title":"Gene expression of tumor necrosis factor [alpha ] and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients","volume":"34","author":"Crespo","year":"2001","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.ejphar.2019.172469_bib10","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1478-3231.2007.01497.x","article-title":"The expression of SIRT1 in nonalcoholic fatty liver disease induced by high-fat diet in rats","volume":"27","author":"Deng","year":"2007","journal-title":"Liver Int."},{"issue":"11","key":"10.1016\/j.ejphar.2019.172469_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/107999003322558782","article-title":"Fever after zoledronic acid administration is due to increase in TNF-\u03b1 and IL-6","volume":"23","author":"Dicuonzo","year":"2003","journal-title":"J. Interferon Cytokine Res."},{"issue":"9","key":"10.1016\/j.ejphar.2019.172469_bib12","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"10.1016\/j.ejphar.2019.172469_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0016-5085(03)00907-7","article-title":"Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis","volume":"125","author":"Feldstein","year":"2003","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ejphar.2019.172469_bib14","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hep.27343","article-title":"Molecular pathophysiology of portal hypertension","volume":"61","author":"Fernandez","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ejphar.2019.172469_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2019.172469_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.ejphar.2019.172469_bib17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00223-008-9123-8","article-title":"The effects of zoledronic acid on serum lipids in multiple myeloma patients","volume":"82","author":"Gozzetti","year":"2008","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.ejphar.2019.172469_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3892\/ijo.2015.2991","article-title":"Zoledronic acid enhances antitumor efficacy of liposomal doxorubicin","volume":"47","author":"HATTORI","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.ejphar.2019.172469_bib19","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4049\/jimmunol.1501080","article-title":"Mevalonate biosynthesis intermediates are key regulators of innate immunity in bovine endometritis","volume":"196","author":"Healey","year":"2015","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.ejphar.2019.172469_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","article-title":"The role of cholesterol in the pathogenesis of NASH","volume":"27","author":"Ioannou","year":"2016","journal-title":"Trends Endocrinol. Metabol."},{"issue":"01","key":"10.1016\/j.ejphar.2019.172469_bib21","first-page":"80","article-title":"Pivotal role of TNF-\u03b1 in the development and progression of nonalcoholic fatty liver disease in a murine model","volume":"50","author":"Kakino","year":"2017","journal-title":"Horm. Metab. Res."},{"issue":"11","key":"10.1016\/j.ejphar.2019.172469_bib22","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/labinvest.2014.112","article-title":"Western diet in ApoE-LDLR double-deficient mouse model of atherosclerosis leads to hepatic steatosis, fibrosis, and tumorigenesis","volume":"94","author":"Kampschulte","year":"2014","journal-title":"Lab. Investig."},{"issue":"9","key":"10.1016\/j.ejphar.2019.172469_bib23","doi-asserted-by":"crossref","first-page":"R200","DOI":"10.1186\/gb-2007-8-9-r200","article-title":"Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis","volume":"8","author":"Kleemann","year":"2007","journal-title":"Genome Biol."},{"issue":"4","key":"10.1016\/j.ejphar.2019.172469_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","article-title":"Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including ras","volume":"13","author":"Luckman","year":"1998","journal-title":"J. Bone Miner. Res."},{"issue":"04","key":"10.1016\/j.ejphar.2019.172469_bib25","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-0028-1091980","article-title":"Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease","volume":"28","author":"Malhi","year":"2008","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ejphar.2019.172469_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/med\/9780199231362.003.0016","article-title":"Complications of cirrhosis and portal hypertension","author":"Marks","year":"2013","journal-title":"Emergencies in Gastroenterology and Hepatology"},{"issue":"1","key":"10.1016\/j.ejphar.2019.172469_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S8756-3282(02)00924-9","article-title":"Changes in serum HDL and LDL cholesterol in patients with paget's bone disease treated with pamidronate","volume":"32","author":"Montagnani","year":"2003","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.ejphar.2019.172469_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cell.2016.02.023","article-title":"The effect of sustained inflammation on hepatic mevalonate pathway results in hyperglycemia","volume":"165","author":"Okin","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2019.172469_bib29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bone.2016.05.002","article-title":"Doses effects of zoledronic acid on mineral apatite and collagen quality of newly-formed bone in the rat's calvaria defect","volume":"89","author":"Olejnik","year":"2016","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.ejphar.2019.172469_bib30","doi-asserted-by":"crossref","first-page":"G193","DOI":"10.1152\/ajpgi.00426.2001","article-title":"V. Mitochondrial dysfunction in steatohepatitis","volume":"282","author":"Pessayre","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.ejphar.2019.172469_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep.1840110114","article-title":"The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years","volume":"11","author":"Powell","year":"1990","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.ejphar.2019.172469_bib32","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.ejphar.2019.172469_bib33","doi-asserted-by":"crossref","first-page":"77166","DOI":"10.1371\/journal.pone.0077166","article-title":"Smooth muscle \u03b1 actin (Acta2) and myofibroblast function during hepatic wound healing","volume":"8","author":"Rockey","year":"2013","journal-title":"PLoS One"},{"issue":"S2","key":"10.1016\/j.ejphar.2019.172469_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jbmr.5650140212","article-title":"The pharmacology of bisphosphonates and new insights into their mechanisms of action","volume":"14","author":"Russell","year":"1999","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2019.172469_bib35","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.1016\/S0168-8278(16)00267-1","article-title":"Correlation between the hepatic venous pressure gradient and alpha-smooth muscle actin (SMA) expression in patients with compensated cirrhosis due to nonalcoholic steatohepatitis","volume":"64","author":"Sanyal","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2019.172469_bib36","series-title":"A Practical Guide to the Histology of the Mouse. 1st edition.Wiley Blackwell","first-page":"17","author":"Scudamore","year":"2014"},{"issue":"9","key":"10.1016\/j.ejphar.2019.172469_bib37","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1194\/jlr.M016246","article-title":"Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice","volume":"52","author":"Subramanian","year":"2011","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.ejphar.2019.172469_bib38","series-title":"Bancroft's Theory and Practice of Histological Techniques","author":"Suvarna","year":"2013"},{"issue":"1","key":"10.1016\/j.ejphar.2019.172469_bib39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.gastro.2011.09.049","article-title":"A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells","volume":"142","author":"Teratani","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.ejphar.2019.172469_bib40","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10620-014-3167-6","article-title":"Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model","volume":"59","author":"Thapaliya","year":"2014","journal-title":"Dig. Dis. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2019.172469_bib41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gut.2005.071118","article-title":"Tumour necrosis factor signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice","volume":"55","author":"Tomita","year":"2006","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.ejphar.2019.172469_bib42","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0024-3205(03)00413-2","article-title":"Role of acute elevation of portal venous pressure by exogenous glucagon on gastric mucosal injury in rats with portal hypertension","volume":"73","author":"Tsui","year":"2003","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.ejphar.2019.172469_bib43","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/jn\/138.10.1866","article-title":"Increased apoptosis in high-fat diet\u2013induced nonalcoholic steatohepatitis in rats is associated with c-jun NH2-terminal kinase activation and elevated proapoptotic bax","volume":"138","author":"Wang","year":"2008","journal-title":"J. Nutr."},{"issue":"8","key":"10.1016\/j.ejphar.2019.172469_bib44","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/cr.2009.73","article-title":"Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells","volume":"19","author":"Wobser","year":"2009","journal-title":"Cell Res."},{"issue":"9","key":"10.1016\/j.ejphar.2019.172469_bib45","first-page":"1165","article-title":"The effect of zoledronic acid on the function and differentiation of myeloid cells","volume":"91","author":"Wolf","year":"2006","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.ejphar.2019.172469_bib46","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.ejphar.2019.172469_bib47","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.22363","article-title":"Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis","volume":"48","author":"Wouters","year":"2008","journal-title":"Hepatology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919304212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919304212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T02:38:15Z","timestamp":1609987095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919304212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":47,"alternative-id":["S0014299919304212"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172469","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zoledronic acid prevents the hepatic changes associated with high fat diet in rats; the potential role of mevalonic acid pathway in nonalcoholic steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172469","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"172469"}}